These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 9517420)
1. AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices. Jin S Neuropharmacology; 1997; 36(11-12):1503-10. PubMed ID: 9517420 [TBL] [Abstract][Full Text] [Related]
2. Role of NMDA, AMPA and kainate receptors in mediating glutamate- and 4-AP-induced dopamine and acetylcholine release from rat striatal slices. Jin S; Fredholm BB Neuropharmacology; 1994 Sep; 33(9):1039-48. PubMed ID: 7838316 [TBL] [Abstract][Full Text] [Related]
3. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Pittaluga A; Bonfanti A; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187 [TBL] [Abstract][Full Text] [Related]
5. Regulation of medial prefrontal cortex dopamine by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptors. Wu WR; Li N; Sorg BA Neuroscience; 2002; 114(2):507-16. PubMed ID: 12204218 [TBL] [Abstract][Full Text] [Related]
6. Crucial role of kainate receptors in mediating striatal kainate injection-induced decrease in acetylcholine M(1) receptor binding in rat forebrain. Jin S; Yang J; Lee WL; Wong PT Brain Res; 2000 Nov; 882(1-2):128-38. PubMed ID: 11056192 [TBL] [Abstract][Full Text] [Related]
7. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors. Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650 [TBL] [Abstract][Full Text] [Related]
9. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences. Fedele E; Conti A; Raiteri M Neuropharmacology; 1997 Oct; 36(10):1393-403. PubMed ID: 9423927 [TBL] [Abstract][Full Text] [Related]
10. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Prehn JH; Lippert K; Krieglstein J Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791 [TBL] [Abstract][Full Text] [Related]
11. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist. Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors. Gemignani A; Marchese S; Fontana G; Raiteri M Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398 [TBL] [Abstract][Full Text] [Related]
13. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Parsons CG; Gruner R; Rozental J Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977 [TBL] [Abstract][Full Text] [Related]
14. Local infusion of the (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum. Keefe KA; Gerfen CR Neuroscience; 1999 Mar; 89(2):491-504. PubMed ID: 10077330 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists. Ghersi C; Bonfanti A; Manzari B; Feligioni M; Raiteri M; Pittaluga A Neurochem Int; 2003 Mar; 42(4):283-92. PubMed ID: 12470701 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain. Dev KK; Petersen V; Honoré T; Henley JM J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496 [TBL] [Abstract][Full Text] [Related]
18. Overactivation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-D-aspartate but not kainate receptors inhibits phosphatidylcholine synthesis before excitotoxic neuronal death. Gasull T; DeGregorio-Rocasolano N; Trullas R J Neurochem; 2001 Apr; 77(1):13-22. PubMed ID: 11279257 [TBL] [Abstract][Full Text] [Related]
19. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. Mathé JM; Nomikos GG; Schilström B; Svensson TH J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002 [TBL] [Abstract][Full Text] [Related]